(Q35142091)

6 August 2017

1 reference

title

Treatment of bipolar depression: current status, continued challenges, and the STEP-BD approach (English)

1 reference

6 August 2017

1 reference

Michael E Thase

1

1 reference

6 August 2017

Manoj Bhargava

series ordinal

2

1 reference

6 August 2017

Gary S Sachs

series ordinal

3

1 reference

6 August 2017

publication date

1 June 2003

1 reference

Psychiatric Clinics of North America

6 August 2017

published in

1 reference

6 August 2017

volume

26

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

495-518

1 reference

Bipolar depression: pharmacotherapy and related therapeutic strategies

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

The long-term natural history of the weekly symptomatic status of bipolar I disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Bipolar depression: an underestimated treatment challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Suicide in bipolar disorder in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Role of newer medications for bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

An open study of lamotrigine in refractory bipolar depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Safety of long-term lamotrigine in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Factors Influencing the Incidence of Lamotrigine-Related Skin Rash

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Lamotrigine-associated rash: risk/benefit considerations in adults and children

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Safety review of adult clinical trial experience with lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Lamotrigine-induced severe cutaneous adverse reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Severe adverse cutaneous reactions to drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Bipolar mood disorder: practical strategies for acute and maintenance phase treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Carbamazepine in manic-depressive illness: a new treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Antidepressant effects of carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Treatment of bipolar depression with carbamazepine: results of an open study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Tolerability of combined treatment with lithium and paroxetine in patients with bipolar disorder and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

"Cade's disease" and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Trends in the treatment of bipolar disorder by outpatient psychiatrists

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Antidepressant-associated mania: a controlled comparison with spontaneous mania

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Citalopram as adjunctive therapy in bipolar depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Treatment of previously intractable depressions with tranylcypromine and lithium

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

A double-blind study of tranylcypromine treatment of major anergic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Tranylcypromine versus imipramine in anergic bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Efficacy of moclobemide in different patient groups: a meta-analysis of studies

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Moclobemide vs. imipramine in bipolar depression: a multicentre double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Psychotherapy for bipolar depression: a phase-specific treatment strategy?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

A pilot study of cognitive therapy in bipolar disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900029-7

7 January 2021

10.1016/S0193-953X(03)00029-7

Identifiers

DOI

1 reference

6 August 2017

1 reference